Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14478
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wangchuk P. | |
dc.contributor.author | Keller P.A. | |
dc.contributor.author | Pyne S.G. | |
dc.contributor.author | Taweechotipatr M. | |
dc.contributor.author | Tonsomboon A. | |
dc.contributor.author | Rattanajak R. | |
dc.contributor.author | Kamchonwongpaisan S. | |
dc.date.accessioned | 2021-04-05T03:35:06Z | - |
dc.date.available | 2021-04-05T03:35:06Z | - |
dc.date.issued | 2011 | |
dc.identifier.issn | 3788741 | |
dc.identifier.other | 2-s2.0-80052032320 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/14478 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052032320&doi=10.1016%2fj.jep.2011.06.032&partnerID=40&md5=411884ccf029a556a5ce6e799fdba168 | |
dc.description.abstract | Ethnopharmacological relevance: As many as 229 medicinal plants have been currently used in the Bhutanese Traditional Medicine (BTM) as a chief ingredient of polyherbal formulations and these plants have been individually indicated for treating various types of infections including malaria, tumor, and microbial. We have focused our study only on seven species of these plants. Aim of the study: We aim to evaluate the antiplasmodial, antimicrobial, anti-Trypanosoma brucei rhodesiense and cytotoxicity activities of the seven medicinal plants of Bhutan selected using an ethno-directed bio-rational approach. This study creates a scientific basis for their use in the BTM and gives foundation for further phytochemical and biological evaluations which can result in the discovery of new drug lead compounds. Materials and methods: A three stage process was conducted which consisted of: (1) an assessment of a pharmacopoeia and a formulary book of the BTM for their mode of plant uses; (2) selecting 25 anti-infective medicinal plants based on the five established criteria, collecting them, and screening for their major classes of phytochemicals using appropriate test protocols; and (3) finally analyzing the crude extracts of the seven medicinal plants, using the standard test protocols, for their antiplasmodial, antimicrobial, anti-Trypanosoma brucei rhodesiense and cytotoxicity activities as directed by the ethnopharmacological uses of each plant. Results: Out of 25 medicinal plants screened for their major classes of phytochemicals, the majority contained tannins, alkaloids and flavonoids. Out of the seven plant species investigated for their biological activities, all seven of them exhibited mild antimicrobial properties, five plants gave significant in vitro antiplasmodial activities, two plants gave moderate anti-Trypanosoma brucei rhodesiense activity, and one plant showed mild cytotoxicity. Meconopsis simplicifolia showed the highest antiplasmodial activity with IC 50 values of 0.40 μg/ml against TM4/8.2 strain (a wild type chloroquine and antifolate sensitive strain) and 6.39 μg/ml against K1CB1 (multidrug resistant strain) strain. Significantly the extracts from this plant did not show any cytotoxicity. Conclusions: These findings provide the scientific basis for the use of seven medicinal plants in the BTM for the treatment of malaria, microbial infections, infectious fevers, and the Trypanosoma brucei rhodesiense infection. The results also form a good preliminary basis for the prioritization of candidate plant species for further in-depth phytochemical and pharmacological investigations toward our quest to unearth lead antiparasitic, anticancer and antimicrobial compounds. © 2011 Elsevier Ireland Ltd All rights reserved. | |
dc.subject | Aconitum laciniatum extract | |
dc.subject | Ajania nubigena extract | |
dc.subject | alkaloid | |
dc.subject | Androsace strigillosa extract | |
dc.subject | antitrypanosomal agent | |
dc.subject | Aster flaccidus extract | |
dc.subject | Butea parviflora extract | |
dc.subject | Capsella bursa pastoris extract | |
dc.subject | Cavea tanguensis extract | |
dc.subject | Chrysosplenium nudicaule extract | |
dc.subject | Codonopsis bhutanica extract | |
dc.subject | Corydalis crispa extract | |
dc.subject | Corydalis dubia extract | |
dc.subject | flavonoid | |
dc.subject | Fraxinus paxiana extract | |
dc.subject | Gentiana urnula extract | |
dc.subject | Knema tenuinervia extract | |
dc.subject | Meconopsis simplicifolia extract | |
dc.subject | Myricarea rosea extract | |
dc.subject | Myrsine semiserrata extract | |
dc.subject | Otochilus lancitabius extract | |
dc.subject | Pedicularis integrifolia extract | |
dc.subject | Pedicularis longiflora extract | |
dc.subject | plant extract | |
dc.subject | Pleurospermum amabile extract | |
dc.subject | Polygonum macrophylla extract | |
dc.subject | Sapria himalayana extract | |
dc.subject | spasmolytic agent | |
dc.subject | unclassified drug | |
dc.subject | unindexed drug | |
dc.subject | Veronica cephaloides extract | |
dc.subject | abscess | |
dc.subject | Aconitum laciniatum | |
dc.subject | African trypanosomiasis | |
dc.subject | Ajania nubigena | |
dc.subject | Androsace strigillosa | |
dc.subject | animal cell | |
dc.subject | anthelmintic activity | |
dc.subject | antibacterial activity | |
dc.subject | antifungal activity | |
dc.subject | antimicrobial activity | |
dc.subject | antiprotozoal activity | |
dc.subject | article | |
dc.subject | ascites | |
dc.subject | Aster flaccidus | |
dc.subject | asthma | |
dc.subject | bark | |
dc.subject | benign tumor | |
dc.subject | Bhutan | |
dc.subject | bile duct disease | |
dc.subject | blood disease | |
dc.subject | bloodstream infection | |
dc.subject | bone disease | |
dc.subject | bone infection | |
dc.subject | Butea parviflora | |
dc.subject | capsella bursapastoris | |
dc.subject | Cavea tanguensis | |
dc.subject | chemosensitivity | |
dc.subject | chickenpox | |
dc.subject | Chrysosplenium nudicaule | |
dc.subject | Codonopsis bhutanica | |
dc.subject | common cold | |
dc.subject | Corydalis crispa | |
dc.subject | Corydalis dubia | |
dc.subject | coughing | |
dc.subject | cytotoxicity test | |
dc.subject | dehydration | |
dc.subject | diarrhea | |
dc.subject | drug activity | |
dc.subject | drug screening | |
dc.subject | dysentery | |
dc.subject | dyspepsia | |
dc.subject | edema | |
dc.subject | epistaxis | |
dc.subject | evaluation | |
dc.subject | eye disease | |
dc.subject | fever | |
dc.subject | flower | |
dc.subject | fracture | |
dc.subject | Fraxinus paxiana | |
dc.subject | gastritis | |
dc.subject | Gentiana urnula | |
dc.subject | gout | |
dc.subject | heart disease | |
dc.subject | hepatitis | |
dc.subject | hypertension | |
dc.subject | IC 50 | |
dc.subject | infection | |
dc.subject | intoxication | |
dc.subject | kidney infection | |
dc.subject | Knema tenuinervia | |
dc.subject | leprosy | |
dc.subject | limb disease | |
dc.subject | liver disease | |
dc.subject | lung infection | |
dc.subject | malaria | |
dc.subject | Meconopsis simplicifolia | |
dc.subject | medical literature | |
dc.subject | medicinal plant | |
dc.subject | menstruation disorder | |
dc.subject | minimum inhibitory concentration | |
dc.subject | multidrug resistance | |
dc.subject | mumps | |
dc.subject | Myricarea rosea | |
dc.subject | Myrsine semiserrata | |
dc.subject | nephritis | |
dc.subject | neuralgia | |
dc.subject | nonhuman | |
dc.subject | Otochilus lancitabius | |
dc.subject | pancreas disease | |
dc.subject | paresthesia | |
dc.subject | Pedicularis integrifolia | |
dc.subject | Pedicularis longiflora | |
dc.subject | Phlogacanthus thyrsiformis | |
dc.subject | Phlogacanthus thyrsiformis extract | |
dc.subject | plant leaf | |
dc.subject | Pleurospermum amabile | |
dc.subject | polydipsia | |
dc.subject | Polygonum macrophylla | |
dc.subject | rheumatic disease | |
dc.subject | rhizome | |
dc.subject | Sapria himalayana | |
dc.subject | skin disease | |
dc.subject | skin tingling | |
dc.subject | stomach pain | |
dc.subject | traditional medicine | |
dc.subject | Trypanosoma brucei | |
dc.subject | tuberculosis | |
dc.subject | ulcer | |
dc.subject | urinary tract obstruction | |
dc.subject | Veronica cephaloides | |
dc.subject | wild type | |
dc.subject | wood | |
dc.subject | wound | |
dc.subject | Animals | |
dc.subject | Anti-Infective Agents | |
dc.subject | Antimalarials | |
dc.subject | Bhutan | |
dc.subject | Cell Line, Tumor | |
dc.subject | Cell Survival | |
dc.subject | Cercopithecus aethiops | |
dc.subject | Dose-Response Relationship, Drug | |
dc.subject | Ethnopharmacology | |
dc.subject | Formularies as Topic | |
dc.subject | Humans | |
dc.subject | Inhibitory Concentration 50 | |
dc.subject | Medicine, Traditional | |
dc.subject | Microbial Sensitivity Tests | |
dc.subject | Pharmacopoeias as Topic | |
dc.subject | Plant Preparations | |
dc.subject | Plants, Medicinal | |
dc.subject | Trypanocidal Agents | |
dc.subject | Trypanosoma brucei rhodesiense | |
dc.subject | Vero Cells | |
dc.subject | Meconopsis simplicifolia | |
dc.subject | Trypanosoma brucei rhodesiense | |
dc.title | Evaluation of an ethnopharmacologically selected Bhutanese medicinal plants for their major classes of Phytochemicals and biological activities | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Journal of Ethnopharmacology. Vol 137, No.1 (2011), p.730-742 | |
dc.identifier.doi | 10.1016/j.jep.2011.06.032 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.